Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 7 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9ATF5
Term | Name | Level | Count |
---|---|---|---|
GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation | 8 | 9 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 9 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 9 | 9 |
GO:0006396 | RNA processing | 6 | 9 |
GO:0006399 | tRNA metabolic process | 7 | 9 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 9 |
GO:0006807 | nitrogen compound metabolic process | 2 | 9 |
GO:0008033 | tRNA processing | 8 | 9 |
GO:0008152 | metabolic process | 1 | 9 |
GO:0008380 | RNA splicing | 7 | 9 |
GO:0009987 | cellular process | 1 | 9 |
GO:0016070 | RNA metabolic process | 5 | 9 |
GO:0034470 | ncRNA processing | 7 | 9 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 9 |
GO:0034660 | ncRNA metabolic process | 6 | 9 |
GO:0043170 | macromolecule metabolic process | 3 | 9 |
GO:0044237 | cellular metabolic process | 2 | 9 |
GO:0044238 | primary metabolic process | 2 | 9 |
GO:0046483 | heterocycle metabolic process | 3 | 9 |
GO:0071704 | organic substance metabolic process | 2 | 9 |
GO:0090304 | nucleic acid metabolic process | 4 | 9 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000213 | tRNA-intron endonuclease activity | 6 | 9 |
GO:0003824 | catalytic activity | 1 | 9 |
GO:0004518 | nuclease activity | 4 | 9 |
GO:0004519 | endonuclease activity | 5 | 9 |
GO:0004521 | RNA endonuclease activity | 5 | 9 |
GO:0004540 | RNA nuclease activity | 4 | 9 |
GO:0004549 | tRNA-specific ribonuclease activity | 5 | 9 |
GO:0016787 | hydrolase activity | 2 | 9 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 9 |
GO:0016892 | RNA endonuclease activity, producing 3'-phosphomonoesters | 6 | 9 |
GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters | 6 | 9 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 9 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 9 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 9 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 172 | 174 | PF00675 | 0.622 |
CLV_NRD_NRD_1 | 53 | 55 | PF00675 | 0.626 |
CLV_NRD_NRD_1 | 72 | 74 | PF00675 | 0.571 |
CLV_PCSK_KEX2_1 | 140 | 142 | PF00082 | 0.492 |
CLV_PCSK_KEX2_1 | 172 | 174 | PF00082 | 0.627 |
CLV_PCSK_KEX2_1 | 33 | 35 | PF00082 | 0.553 |
CLV_PCSK_KEX2_1 | 53 | 55 | PF00082 | 0.373 |
CLV_PCSK_KEX2_1 | 74 | 76 | PF00082 | 0.533 |
CLV_PCSK_PC1ET2_1 | 140 | 142 | PF00082 | 0.492 |
CLV_PCSK_PC1ET2_1 | 33 | 35 | PF00082 | 0.577 |
CLV_PCSK_PC1ET2_1 | 74 | 76 | PF00082 | 0.533 |
CLV_PCSK_PC7_1 | 136 | 142 | PF00082 | 0.492 |
CLV_PCSK_SKI1_1 | 141 | 145 | PF00082 | 0.415 |
CLV_Separin_Metazoa | 70 | 74 | PF03568 | 0.573 |
DEG_APCC_DBOX_1 | 140 | 148 | PF00400 | 0.415 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.569 |
DEG_SCF_TRCP1_1 | 151 | 157 | PF00400 | 0.600 |
DOC_MAPK_gen_1 | 140 | 147 | PF00069 | 0.492 |
DOC_MAPK_gen_1 | 53 | 60 | PF00069 | 0.563 |
DOC_MAPK_MEF2A_6 | 140 | 147 | PF00069 | 0.438 |
DOC_PP4_FxxP_1 | 119 | 122 | PF00568 | 0.391 |
DOC_USP7_MATH_1 | 174 | 178 | PF00917 | 0.671 |
DOC_WW_Pin1_4 | 152 | 157 | PF00397 | 0.500 |
LIG_14-3-3_CanoR_1 | 133 | 139 | PF00244 | 0.357 |
LIG_14-3-3_CanoR_1 | 53 | 60 | PF00244 | 0.349 |
LIG_Actin_WH2_2 | 38 | 55 | PF00022 | 0.495 |
LIG_Actin_WH2_2 | 79 | 97 | PF00022 | 0.361 |
LIG_DCNL_PONY_1 | 1 | 4 | PF03556 | 0.555 |
LIG_FHA_1 | 118 | 124 | PF00498 | 0.454 |
LIG_FHA_1 | 155 | 161 | PF00498 | 0.607 |
LIG_FHA_1 | 53 | 59 | PF00498 | 0.534 |
LIG_FHA_2 | 110 | 116 | PF00498 | 0.469 |
LIG_FHA_2 | 144 | 150 | PF00498 | 0.415 |
LIG_FHA_2 | 157 | 163 | PF00498 | 0.581 |
LIG_HCF-1_HBM_1 | 89 | 92 | PF13415 | 0.492 |
LIG_LIR_Gen_1 | 166 | 174 | PF02991 | 0.607 |
LIG_LIR_Gen_1 | 67 | 77 | PF02991 | 0.574 |
LIG_LIR_Nem_3 | 166 | 171 | PF02991 | 0.595 |
LIG_LIR_Nem_3 | 67 | 72 | PF02991 | 0.526 |
LIG_SH2_CRK | 83 | 87 | PF00017 | 0.391 |
LIG_SH2_SRC | 107 | 110 | PF00017 | 0.438 |
LIG_SH2_STAT5 | 104 | 107 | PF00017 | 0.383 |
LIG_SH2_STAT5 | 23 | 26 | PF00017 | 0.517 |
LIG_SUMO_SIM_anti_2 | 43 | 50 | PF11976 | 0.558 |
LIG_SUMO_SIM_par_1 | 143 | 149 | PF11976 | 0.442 |
LIG_SUMO_SIM_par_1 | 155 | 162 | PF11976 | 0.603 |
LIG_TRAF2_1 | 146 | 149 | PF00917 | 0.415 |
LIG_TRAF2_1 | 41 | 44 | PF00917 | 0.425 |
LIG_TYR_ITIM | 105 | 110 | PF00017 | 0.357 |
LIG_TYR_ITIM | 81 | 86 | PF00017 | 0.376 |
MOD_CK1_1 | 152 | 158 | PF00069 | 0.657 |
MOD_CK1_1 | 62 | 68 | PF00069 | 0.593 |
MOD_CK2_1 | 109 | 115 | PF00069 | 0.427 |
MOD_CK2_1 | 143 | 149 | PF00069 | 0.500 |
MOD_CK2_1 | 38 | 44 | PF00069 | 0.430 |
MOD_Cter_Amidation | 138 | 141 | PF01082 | 0.492 |
MOD_GlcNHglycan | 151 | 154 | PF01048 | 0.706 |
MOD_GlcNHglycan | 16 | 19 | PF01048 | 0.545 |
MOD_GlcNHglycan | 35 | 38 | PF01048 | 0.301 |
MOD_GlcNHglycan | 61 | 64 | PF01048 | 0.557 |
MOD_GSK3_1 | 10 | 17 | PF00069 | 0.467 |
MOD_GSK3_1 | 152 | 159 | PF00069 | 0.577 |
MOD_GSK3_1 | 43 | 50 | PF00069 | 0.409 |
MOD_NEK2_1 | 117 | 122 | PF00069 | 0.467 |
MOD_NEK2_1 | 143 | 148 | PF00069 | 0.415 |
MOD_NEK2_1 | 164 | 169 | PF00069 | 0.555 |
MOD_NEK2_1 | 47 | 52 | PF00069 | 0.494 |
MOD_NEK2_2 | 174 | 179 | PF00069 | 0.672 |
MOD_PIKK_1 | 47 | 53 | PF00454 | 0.410 |
MOD_PIKK_1 | 95 | 101 | PF00454 | 0.379 |
MOD_PKA_1 | 33 | 39 | PF00069 | 0.518 |
MOD_PKA_2 | 33 | 39 | PF00069 | 0.573 |
MOD_PKA_2 | 52 | 58 | PF00069 | 0.331 |
MOD_PKB_1 | 93 | 101 | PF00069 | 0.415 |
MOD_Plk_1 | 43 | 49 | PF00069 | 0.509 |
MOD_Plk_4 | 43 | 49 | PF00069 | 0.538 |
MOD_ProDKin_1 | 152 | 158 | PF00069 | 0.483 |
TRG_DiLeu_BaEn_1 | 43 | 48 | PF01217 | 0.532 |
TRG_DiLeu_BaEn_4 | 43 | 49 | PF01217 | 0.402 |
TRG_ENDOCYTIC_2 | 107 | 110 | PF00928 | 0.357 |
TRG_ENDOCYTIC_2 | 83 | 86 | PF00928 | 0.379 |
TRG_ER_diArg_1 | 171 | 173 | PF00400 | 0.653 |
TRG_ER_diArg_1 | 52 | 54 | PF00400 | 0.581 |
TRG_ER_diArg_1 | 72 | 75 | PF00400 | 0.524 |
TRG_ER_diArg_1 | 92 | 95 | PF00400 | 0.162 |
TRG_NLS_MonoExtN_4 | 29 | 36 | PF00514 | 0.539 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P4T2 | Leptomonas seymouri | 57% | 85% |
A0A1X0P3G1 | Trypanosomatidae | 43% | 87% |
A0A3Q8IKM3 | Leishmania donovani | 93% | 100% |
A4HPP1 | Leishmania braziliensis | 83% | 100% |
A4ID23 | Leishmania infantum | 93% | 100% |
D0A8H3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 41% | 72% |
Q4Q142 | Leishmania major | 95% | 100% |